Abstract Body

Depression affects 20-30% of HIV-infected adults and contributes to suboptimal antiretroviral therapy (ART) adherence and ability to maintain viral suppression. Reduced ART adherence and viral suppression associated with depression may lead to an increased risk of mortality. Depression may also independently predict an increased risk of mortality. However, the relationship between depression and mortality remains understudied in large, representative clinical cohorts of adults in HIV care.

We estimated the association between depression and all-cause mortality using data from CNICS, a cohort of over 30,000 HIV-infected adults engaged in HIV care across 8 sites in the United States. CNICS collects comprehensive HIV clinical information on ART use, adherence, HIV-related labs and clinical events and vital status. Depression information in CNICS is collected by self-report using the Patient Health Questionnaire-9 (PHQ-9) at 7 of the 8 sites. Participants were included in the present analysis if they entered care between October 2004 and November 2014 and had a PHQ-9 measure within 1 year. Vital status was ascertained for all individuals. Participants were followed until death or administrative censoring (May-November 2014, depending on site), whichever date came first. Depression was defined as a PHQ-9 ≥ 10. We used Cox proportional hazards models to estimate the association between depression within 1 year of entering care and time to all-cause mortality.

4,029 adults were included for a total follow-up of 10,242 person years. Nearly a third of adults (n=1,246, 31%) met the definition for depression during their first year after enrollment. Overall, 122 (3%) of participants died during the follow-up period. Depression increased the hazard of mortality by 68% (HR 1.68; 95% CI 1.09, 2.59), after adjustment for site, gender, race/ethnicity, HIV acquisition risk group and  age, alcohol dependence, panic disorder, ART status and adherence, viral load, and CD4 count at enrollment.

Depression increased the hazard of mortality among HIV-infected adults in care even after adjustment for adherence, CD4 count, viral suppression at enrollment and a number of other clinical and demographic factors. Interventions to improve depression treatment and reduce depression are urgently needed to reduce the risk of mortality among HIV-infected persons.